MRD levels during the first months of treatment indicate relapses in children with t(12;21)-positive ALL

Leukemia. 2000 Sep;14(9):1707-8. doi: 10.1038/sj.leu.2401882.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / metabolism*
  • Child
  • Child, Preschool
  • Chromosomes, Human, Pair 12*
  • Chromosomes, Human, Pair 21*
  • Core Binding Factor Alpha 2 Subunit
  • Humans
  • Neoplasm, Residual / genetics
  • Neoplasm, Residual / metabolism*
  • Oncogene Proteins, Fusion / metabolism*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / metabolism*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / prevention & control
  • Receptors, Antigen / genetics
  • Recurrence
  • Translocation, Genetic*

Substances

  • Biomarkers, Tumor
  • Core Binding Factor Alpha 2 Subunit
  • Oncogene Proteins, Fusion
  • Receptors, Antigen
  • TEL-AML1 fusion protein